KRAS and lymph node neoplasm: Surprisingly, after analysing and comparing the impractical KRAS (those with metachronous and negative lymph node tumours) with KRAS mutated or KRAS wild-type patients, the difference in terms of HRFS, DFS and OS sharply increased over the others.